Aterian Reports 91.9% Revenue Decline in Q2 2026 Amid Macroeconomic Challenges

Aterian, Inc. reported a significant decline in financial performance for the second quarter of 2026, with net revenue dropping to $7,000, a decrease of 91.9% compared to $88,000 in the same period last year. For the first half of 2026, the company generated $25,000 in revenue, down 83.4% from $151,000 in the first half of 2025. The company attributed this decline primarily to reduced consumer demand amid challenging macroeconomic conditions. Gross profit also fell sharply, with a gross profit of $1,000 for the second quarter, down from $41,000 a year earlier, reflecting a gross margin of just 14.0%.

Operating expenses for Aterian increased to $3.96 million in the second quarter, up from $3.62 million in the prior year, driven largely by a rise in general and administrative costs, which rose by 46% to $3.77 million. The company reported an operating loss of $3.96 million for the quarter, compared to a loss of $3.58 million in the same quarter of 2025. Interest expenses decreased slightly to $173,000 from $222,000, while the company recognized a gain of $295,000 from the extinguishment of debt during the quarter.

In a strategic move, Aterian completed the sale of its marquee consumer brands to Trademark Global for $18 million in cash on July 17, 2026. This transaction, part of a broader restructuring effort, has been classified as discontinued operations in the financial statements. The company also issued 1.75 million shares of preferred stock to David E. Lazar, raising $7 million to support its ongoing operations. Following these transactions, Aterian's remaining operations will focus on its legacy brands, primarily Vremi and Xtava.

As of June 30, 2026, Aterian's total assets were reported at $23.53 million, down from $29.57 million at the end of 2025. The company’s cash reserves decreased to $2.55 million from $4.86 million, while total liabilities also fell to $10.91 million from $14.13 million. The company’s stockholders' equity decreased to $12.62 million from $15.21 million, reflecting the ongoing challenges in its operational performance and the impact of the asset sale.

Looking ahead, Aterian's management expressed concerns regarding its ability to continue as a going concern, citing ongoing macroeconomic pressures and the need for operational efficiencies. The company plans to utilize the proceeds from the asset sale and preferred stock issuance to stabilize its financial position and support its remaining business segments. However, the uncertainty surrounding future cash flows and operational scaling remains a significant risk for the company.